Login
← Go Back
Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023
Stock Price vs Company Growth
1d
3.0%
1w
9.4%
1m
14.1%
3m
7.8%
6m
36.8%
1y
50.7%
all
54.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,910 3.0%
2,405
3,050
Company Overview
Sales
11,018 Cr
Growth: 15.5%
Profit after Tax
2,115 Cr
Growth: 7.8%
Large Cap
1,20,073 Cr
P/E: 55.2x
Industry P/E: 37.1x
Fundamentals
Sales (Cr) ₹ 11,018
Growth 15.5%
EBITDA 24.8%
P/S 10.9x
Dividend 0.0%
P/E 55.2x
Book Value ₹ 256
PEG Ratio 3.6x
ROE 21.9%
P/B 11.4x
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Belongs to (21 Indices) view more